<VariationArchive VariationID="139588" VariationName="NM_000318.3(PEX2):c.279_283del (p.Arg94fs)" VariationType="Deletion" Accession="VCV000139588" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-17" DateCreated="2018-01-03" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="143213" VariationID="139588">
      <GeneList>
        <Gene Symbol="PEX2" FullName="peroxisomal biogenesis factor 2" GeneID="5828" HGNC_ID="HGNC:9717" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q21.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="76980258" stop="77001044" display_start="76980258" display_stop="77001044" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="77892493" stop="77913279" display_start="77892493" display_stop="77913279" Strand="-" />
          </Location>
          <OMIM>170993</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000318.3(PEX2):c.279_283del (p.Arg94fs)</Name>
      <CanonicalSPDI>NC_000008.11:76983895:ATCTCA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q21.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="76983896" stop="76983900" display_start="76983896" display_stop="76983900" variantLength="5" positionVCF="76983895" referenceAlleleVCF="TATCTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="77896132" stop="77896136" display_start="77896132" display_stop="77896136" variantLength="5" positionVCF="77896131" referenceAlleleVCF="TATCTC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>R94fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.77896133_77896137del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.77896133_77896137del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.76983897_76983901del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.76983897_76983901del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008371.1" sequenceAccession="NG_008371" sequenceVersion="1" change="g.21389_21393del">
            <Expression>NG_008371.1:g.21389_21393del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000318.3" sequenceAccession="NM_000318" sequenceVersion="3" change="c.279_283del" MANESelect="true">
            <Expression>NM_000318.3:c.279_283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000309.2" sequenceAccession="NP_000309" sequenceVersion="2" change="p.Arg94fs">
            <Expression>NP_000309.2:p.Arg94fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079867.2" sequenceAccession="NM_001079867" sequenceVersion="2" change="c.279_283del">
            <Expression>NM_001079867.2:c.279_283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073336.2" sequenceAccession="NP_001073336" sequenceVersion="2" change="p.Arg94fs">
            <Expression>NP_001073336.2:p.Arg94fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172086.2" sequenceAccession="NM_001172086" sequenceVersion="2" change="c.279_283del">
            <Expression>NM_001172086.2:c.279_283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165557.2" sequenceAccession="NP_001165557" sequenceVersion="2" change="p.Arg94fs">
            <Expression>NP_001165557.2:p.Arg94fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172087.2" sequenceAccession="NM_001172087" sequenceVersion="2" change="c.279_283del">
            <Expression>NM_001172087.2:c.279_283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165558.2" sequenceAccession="NP_001165558" sequenceVersion="2" change="p.Arg94fs">
            <Expression>NP_001165558.2:p.Arg94fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000318.3" sequenceAccession="NM_000318" sequenceVersion="3" change="c.279_283delGAGAT" MANESelect="true">
            <Expression>NM_000318.3:c.279_283delGAGAT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000318.2" sequenceAccession="NM_000318" sequenceVersion="2" change="c.279_283delGAGAT">
            <Expression>NM_000318.2:c.279_283delGAGAT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000318.2" sequenceAccession="NM_000318" sequenceVersion="2" change="c.279_283del">
            <Expression>NM_000318.2:c.279_283del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA163283" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="170993.0003" DB="OMIM" />
        <XRef Type="rs" ID="61752122" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000318.3(PEX2):c.279_283del (p.Arg94fs) AND Peroxisome biogenesis disorder 5A (Zellweger)" Accession="RCV000128529" Version="12">
        <ClassifiedConditionList TraitSetID="8951">
          <ClassifiedCondition DB="MedGen" ID="C3553940">Peroxisome biogenesis disorder 5A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-14" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000318.3(PEX2):c.279_283del (p.Arg94fs) AND Peroxisome biogenesis disorder" Accession="RCV000781714" Version="1">
        <ClassifiedConditionList TraitSetID="7944">
          <ClassifiedCondition DB="MedGen" ID="C1832200">Peroxisome biogenesis disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-05-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000318.3(PEX2):c.279_283del (p.Arg94fs) AND Zellweger spectrum disorders" Accession="RCV001275875" Version="1">
        <ClassifiedConditionList TraitSetID="55427">
          <ClassifiedCondition DB="MedGen" ID="C0043459">Zellweger spectrum disorders</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-14" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-01-03" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10652207</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14630978</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17432" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 5A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013932" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD5A</ElementValue>
                <XRef Type="MIM" ID="614866" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15861" />
                <XRef ID="15861" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553940" DB="MedGen" />
              <XRef ID="MONDO:0013932" DB="MONDO" />
              <XRef Type="MIM" ID="614866" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7944" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5752" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE PHYTANIC ACID STORAGE DISEASE</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NALD/IRD)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALD: Adrenoleukodystrophy, X-Linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
                <XRef ID="Peroxisome+biogenesis+disorders/5684" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder</ElementValue>
                <XRef ID="INHP_50" DB="Ege University Pediatric Genetics, Ege University" />
                <XRef ID="MONDO:0019234" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBDS</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PBD, ZSS</ElementValue>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11890" />
                <XRef ID="11890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501629" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501632" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525961" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501647" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501630" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318886" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501473" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501466" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501635" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501628" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028499" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501631" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501474" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501626" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004880" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501644" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070509" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501472" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520399" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="79189" DB="Orphanet" />
              <XRef ID="C1832200" DB="MedGen" />
              <XRef ID="MONDO:0019234" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="55427" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="52389" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Zellweger syndrome</ElementValue>
                <XRef ID="912" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Zellweger spectrum disorders</ElementValue>
                <XRef ID="MONDO:0019609" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum Disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ZS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ZWS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7917" />
                <XRef ID="7917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C0043459" DB="MedGen" />
              <XRef ID="MONDO:0019609" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="299507" SubmissionDate="2017-03-06" DateLastUpdated="2018-01-03" DateCreated="2014-07-11">
        <ClinVarSubmissionID localKey="170993.0003_PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)" title="PEX2, 5-BP DEL, NT279_PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)" />
        <ClinVarAccession Accession="SCV000172179" DateUpdated="2018-01-03" DateCreated="2014-07-11" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a male newborn with Zellweger syndrome (PBD5A; 614866), Gootjes et al. (2004) identified a homozygous deletion of 5 basepairs (c.279_283delGAGAT), resulting in a frameshift (Arg94fs98Ter) and termination of the protein before the first transmembrane domain. The patient was the fourth child of a first-cousin union and presented with severe respiratory distress, seizures, and severe hypotonia after delivery. He had polycystic kidneys bilaterally, and visual evoked potentials were absent. Levels of very long chain fatty acids and pipecolic acid were elevated. The boy died at the age of 2 months.</Attribute>
              <Citation>
                <ID Source="PubMed">14630978</ID>
              </Citation>
              <XRef DB="OMIM" ID="614866" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX2" />
          </GeneList>
          <Name>PEX2, 5-BP DEL, NT279</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, NT279</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="170993.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1796598" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_000318.2:c.279_283delGAGAT|MedGen:C1832200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000919977" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14630978</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Comment>Variant summary: PEX2 c.279_283delGAGAT (p.Arg94SerfsX5) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.339_345delCAGGTGG (p.Arg114fsX1), c.355C&gt;T (p.Arg119X)). The variant allele was found at a frequency of 1.6e-05 in 246158 control chromosomes. This frequency is not higher than expected for a pathogenic variant in PEX2 causing Zellweger Syndrome (1.6e-05 vs 0.0011), allowing no conclusion about variant significance. The variant, c.279_283delGAGAT, has been reported in the literature in at least two homozygous individuals and a compound heterozygous individual affected with Zellweger Syndrome (Gootjes 2004, Ebberink_2011). Gootjes et al. also reported experimental evidence evaluating an impact on protein function, demonstrating an absence of peroxisomes and severely decreased peroxisomal enzyme activities in patient fibroblasts. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000318.2:c.279_283delGAGAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1832200" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7854811" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000318.2:c.279_283del|OMIM:614866" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201482" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000318.2:c.279_283del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614866" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2876797" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000318.3:c.279_283delGAGAT|Zellweger syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001461522" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000318.3:c.279_283delGAGAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Zellweger syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3108438" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4876905|MedGen:C3553940" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582806" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10652207</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg94Serfs*5) in the PEX2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 212 amino acid(s) of the PEX2 protein. This variant is present in population databases (rs61752122, gnomAD 0.003%). This premature translational stop signal has been observed in individuals with Zellweger syndrome spectrum (PMID: 21031596). ClinVar contains an entry for this variant (Variation ID: 139588). This variant disrupts a region of the PEX2 protein in which other variant(s) (p.Arg184Valfs*8) have been determined to be pathogenic (PMID: 10652207; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.77896132_77896136del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553940" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7854811" TraitType="Disease" MappingType="XRef" MappingValue="614866" MappingRef="OMIM">
        <MedGen CUI="C3553940" Name="Peroxisome biogenesis disorder 5A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1796598" TraitType="Disease" MappingType="Name" MappingValue="Peroxisome biogenesis disorders, Zellweger syndrome spectrum" MappingRef="Preferred">
        <MedGen CUI="C1832200" Name="Peroxisome biogenesis disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="299507" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)" MappingRef="Preferred">
        <MedGen CUI="C3553940" Name="Peroxisome biogenesis disorder 5A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3108438" TraitType="Disease" MappingType="XRef" MappingValue="C3553940" MappingRef="MedGen">
        <MedGen CUI="C3553940" Name="Peroxisome biogenesis disorder 5A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2876797" TraitType="Disease" MappingType="Name" MappingValue="Zellweger syndrome" MappingRef="Preferred">
        <MedGen CUI="C0043459" Name="Zellweger spectrum disorders" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

